2017 International Congress Archives - Page 53 of 155

Haploinsufficiency of KMT2B causes myoclonus-dystonia with impaired psychomotor ability

T. Kawarai, R. Miyamoto, H. Mure, R. Morigaki, R. Oki, A. Orlacchio, R. Koichihara, E. Nakagawa, T. Sakamoto, Y. Izumi, S. Goto, R. Kaji (Tokushima, Japan)
Head tremor in supine position does not differentiate essential tremor and cervical dystonia

E. Ruzicka, R. Krupicka, T. Duspivova, O. Ulmanova, P. Holly, V. Cejka, J. Rusz, R. Jech (Praha, Czech Republic)
Head turning onset and velocity in response to a peripheral visual stimulus in cervical dystonia patients, their unaffected relatives with and without abnormal temporal discrimination and healthy controls.

I. Beiser, B. Quinlivan, E. McGovern, L. Williams, S. Narasimham, O. Killian, R. Beck, S. O'Riordan, J. Butler, R. Reilly, M. Hutchinson (Dublin 4, Ireland)
Health related QoL as measured by the EQ-5D-5L in PD patients after DBS therapy: Preliminary results from the Product Surveillance Registry

M. Schiess, J. Krauss, J.-P. Azulay, E. Cuny, A. Lopez Rios, F. Farrokhi, S. Blond, T. Witt, C. Raftopoulos, J. Vesper, B. Van Dorn, T. Weaver, P. Konrad, S. Falowski, S. Palfi (Houston, TX, USA)
Healthcare Utilization and Costs for Patients With Tardive Dyskinesia

B. Carroll, T. Park, D. Irwin, S. Gandhi (Frazer, PA, USA)
Heart rate variability in Parkinson’s Disease and idiopathic REM sleep behavior disorder and relation with other non-motor symptoms

P. Bugalho, M. Mendonça, T. Lampreia, R. Miguel, R. Barbosa, M. Salavisa (Lisbon, Portugal)
Helicobacter pylori eradication and risk of Parkinson’s disease in patients with peptic ulcers

Y.-P. Chang, G.-F. Chiu, Y.-H. Chang, D.-C. Wu (Kaohsiung, Taiwan)
Hemidystonia Associated with Alexander Disease

D. Vijayakumar, R. Lewis, G. Fuller, S. Dhar, K. Machol, L. Robak, J. Jankovic (Houston, TX, USA)
Hereditary spastic paraplegia type 31: a novel splice site donor mutation and intra-familial phenotypic variability

M. Kamada, T. Kawarai, R. Miyamoto, Y. Tojima, A. Orlacchio, R. Kaji (Kita-gun, Japan)
High intensity interval training improves psychomotor function in individuals with Parkinson’s disease

J. Marusiak, B. Fisher, A. Jaskólska, K. Słotwinski, S. Budrewicz, M. Koszewicz, K. Kisiel-Sajewicz, A. Jaskólski (Wroclaw, Poland)
High systolic blood pressure is associated with cognitive impairment in Parkinson’s disease (PD)

H. Chan, Y. Cheung, T. Fung, A. Leung, W. Fong (Hong Kong, Hong Kong)
High-mobility group box 1 from astrocytes upregulates TH expression to maintain dopaminergic neurons via JNK pathway in human Parkinson’s disease patients and MPTP induced mouse model

S.J. Kim, M.J. Ryu, J. Han, Y. Jang, J. Kim, M.J. Lee, I. Ryu, X. Ju, W. Chung, E. Oh, G.R. Kweon (Daejeon, Republic of Korea)
High-Pass Filtered Phase MR Imaging to Detect Longitudinal Motor Associations of Iron Accumulation in Parkinson’s Disease

A. Martin-Bastida, N. Lao-Kaim, Y. Xing, C. Loane, A. Roussakis, S. Schwarz, N. Valle-Guzman, P. Mahlknecht, X. Li, G. Paul-Visse, H. Widner, M. Politis, T. Foltynie, R. Barker, D. Auer, P. Piccini (London, United Kingdom)
High-Resolution Manometry (HRM) in Parkinson’s Disease (PD)

S. Brillman, C. Barlow, J. Cedarbaum, R. Gandhy, J. Langston, L. Rees, A. Su, G. Triadafilopoulos (Sunnyvale, CA, USA)
Higher genetic load is associated with an earlier disease onset but not with more rapid disease progression in Parkinson’s disease

S. Lerche, I. Wurster, B. Roeben, E. Schaeffer, C. Schulte, S. Akbas, A.-K. Hauser, C. Deuschle, T. Gasser, D. Berg, K. Brockmann (Tuebingen, Germany)
Higher risk of cognitive impairment in Parkinson’s disease with comorbid diabetes

P. Schmidt, F. Cubillos, K. Lyons, C. Marras, T. Davis, E. Nelson, M. Okun (Miami, FL, USA)
Hippocampal iron deposition in Parkinson disease and Parkinson disease with dementia/Lewy body dementia: quantitative susceptibility mapping assessments

M. Miyata, S. Kakeda, J. Moriya, H. Narimatsu, T. Sato, H. Adachi, Y. Wang, Y. Korogi (Kitakyushu, Japan)
Histological analysis of α-synuclein pathology in the circadian system in Parkinson’s disease

E. De Pablo-Fernandez, J. Holton, T. Warner (London, United Kingdom)
History and Management of Status Dystonicus

E. Nerrant, V. GONZALEZ, C. MILESI, T. Roujeau, E. Chan Seng, F. Cyprien, G. Cambonie, P. Coubes, L. CIF (Montpellier, France)
Holmes’ tremor and olivary hypertrophy: lessons from this neuroanatomical correlation

R. Ellis, S. Biswas, R. Pullicino, J. Panicker, B. Hammersley, J. Farah, S. Alusi (Liverpool, United Kingdom)
Home-based step training using videogame technology in people with Parkinson’s disease: a randomized controlled trial

J. SONG, S. Paul, M.J. Caetano, S. Smith, L. Dibble, R. Love, D. Schoene, J. Menant, C. Sherrington, S. Lord, C. Canning, N. Allen (Ultimo, NSW, Australia)
How common are the genomic rearrangements among possibly autosomal recessive PD cases in Turkey?

G. Yalcin Cakmakli, A. Yuzbasioglu, G. Onal, B. Peynircioglu, M. Ozguc, S. Dokmeci (Emre), B. Elibol (Ankara, Turkey)
How do ataxias with oculomotor apraxia look and look like? A comparative controlled multimodal study of AT, AOA1 and AOA2 focusing on video-oculography.

L.-L. MARIANI, S. Rivaud-Péchoux, B. Gaymard, M. Anheim (Paris, France)
How do Parkinson’s Disease patients manage Ramadan Fasting?

W. Kamel, P. Damier, J. Al-Hashel (Kuwait, Kuwait)
How efficient is subthalamic deep brain stimulation in reducing dyskinesia in Parkinson’s Disease?

N. Kovacs, A. Juhász, I. Balás (Pecs, Hungary)
How to switch from Entacapone to Opicapone based on BIPARK-I study experience

J. Ferreira, A. Lees, A. Santos, B. Hernandez, F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
How Usual Is Skin Rashes During Treatment With Levodopa / Benserazide Hydrochloride?

E. Okuyucu, M. Uzel, S. Colakoglu Yesıldag, M. Guntel (Hatay, Turkey)
How will new technology change deep brain stimulation programming?

G. Duffley, A. Schiewe, B. Lutz, J. Krüger, M. Okun (Salt Lake City, UT, USA)
Hung up knee jerk reflex in Huntington’s disease: A clinical and neurophysiological study

J. Perez-Perez, J. Diaz-Manera, J. Pagonabarraga, S. Martinez-Horta, M. Carceller, A. Horta, J. Marin, H. Bejr-Kasen, A. Guerrero, J. Kulisevsky (Barcelona, Spain)
Huntington’s disease in the Republic of Tatarstan, epidemiological features

S. Munasipova, Z. Zalyalova (Kazan, Russian Federation)
Huntington’s Disease Regulatory Science Consortium (HD-RSC): Enabling Pathways to Effective Treatments Through Regulatory Science and Innovation

C. Fitzer-Attas, D. Stephenson, K. Romero, J. Neville, C. Sampaio (Critical Path Institute, Tucson, AZ; CHDI Foundation, Princeton, NJ)
Huntington’s Disease: Determinants for Cognitive Disease Progression – A Proposed Model

N. Gonçalves, J. Mendes, J. Ferreira, C. Sampaio (Lisbon, Portugal)
Hypertension and Parkinson’s disease

B. Giordano, G. Pagano, J. Hood, N. Ferrara, M. Politis (London, United Kingdom)
Hypertrophic Olivary Degeneration

G. Moreno, K. Ng, A. Duffy (Sacramento, CA, USA)
Hypometabolism in Orbitofrontal and Perirhinal Cortex is Associated with Impulse Control Disorder in Parkinson´s Disease

I. Navalpotro-Gomez, A. Botas-Peñín, F. Molinet-Dronda, C. Gasca-Salas, M. Carmona-Abellán, H. Jiménez-Urbieta, M. Delgado-Alvarado, A. Quiroga-Varela, B. Gago, M.C. Rodríguez-Oroz (San Sebastian, Spain)
Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC): a Mexican case report.

A. Kleinert-Altamirano, J. Patricio-Villagran, M. Fiesco-Roa, M. Gutierrez-Arriola (Tuxtla Gutierrez, Mexico)